Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Type of study
Document Type
Year range
1.
Inserto BEN Bollettino Epidemiologico Nazionale ; 3(2):1-9, 2022.
Article in Italian | GIM | ID: covidwho-2002913

ABSTRACT

Introduction: The Istituto Superiore di Sanita and the Agenzia Italiana del Farmaco coordinate the project TheShinISS-Vax, Flu, a post-marketing "active" surveillance of influenza vaccines. We report the results of the investigation using the Self- Controlled Case Series (SCCS) design on influenza vaccine and Guillain-Barre syndrome in vaccinated population aged over than 6 months, during the influenza vaccine campaign 2020-2021 in Italy. Materials and methods: A SCCS multi-regional study was carried out using linked data from Regional Health Care Registries of Valle d'Aosta, Friuli Venezia Giulia, Emilia-Romagna, Toscana, Lazio, Campania, and Puglia. Relative incidence of Guillain-Barre syndrome was estimated, comparing the exposure risk periods (0-41 days from the vaccination day, subdivided in six intervals) with the unexposed period.

2.
AJNR Am J Neuroradiol ; 41(12): 2206-2208, 2020 12.
Article in English | MEDLINE | ID: covidwho-724225

ABSTRACT

We describe the case of a 63-year-old woman who developed a coronavirus disease 2019-associated acute encephalopathy with perivascular gadolinium enhancement.


Subject(s)
COVID-19/complications , Posterior Leukoencephalopathy Syndrome/pathology , Posterior Leukoencephalopathy Syndrome/virology , Contrast Media , Female , Gadolinium , Humans , Magnetic Resonance Imaging/methods , Middle Aged , Posterior Leukoencephalopathy Syndrome/diagnostic imaging , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL